FUTURE-DEVELOPMENTS IN THROMBOLYTIC THERAPY

被引：0

作者：

BODE, C ^{[1
]}

RUNGE, MS ^{[1
]}

机构：

[1] EMORY UNIV,SCH MED,DIV CARDIOL,ATLANTA,GA 30322

来源：

ZEITSCHRIFT FUR KARDIOLOGIE | 1993年 / 82卷

关键词：

PLASMINOGEN ACTIVATORS; ANTITHROMBINS; THROMBOLYSIS; ANTIBODY-MEDIATED THROMBOLYSIS;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A primary failure rate to achieve reperfusion by thrombolytic therapy in acute myocardial infarction of 20-40%, an early reocclusion rate of 5-20%, as well as an increased risk of bleeding that excludes many patients from this form of therapy are today considered main problems. Better application of conventional thrombolytic agents, new conjunctive therapies and development of improved plasminogen activators are investigated with the aim of minimizing these problems.

引用

页码：187 / 190

页数：4

共 50 条

[1] The present and the future for catheter-directed thrombolytic therapy
Bettmann, MA
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 1995, 6 (06) : S1 - S2
[2] Age and thrombolytic therapy
Ridker, PM
Hennekens, CH
CIRCULATION, 1996, 94 (08) : 1807 - 1808
[3] THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION - CURRENT STATUS, CONTROVERSIES AND PERSPECTIVES FOR THE FUTURE
BODE, C
NORDT, T
VONHODENBERG, E
HABER, E
KUBLER, W
INNERE MEDIZIN, 1991, 18 (02) : 35 - 41
[4] THROMBOLYTIC THERAPY
LITTLER, WA
SAUDI MEDICAL JOURNAL, 1994, 15 (02) : 91 - 98
[5] Thrombolytic therapy in children
Albisetti, M
THROMBOSIS RESEARCH, 2006, 118 (01) : 95 - 105
[6] Passivating Injured Endothelium with Kinexins in Thrombolytic Therapy
Ma, Yunn-Hwa
Huang, Chao-Wei
Wen, Chih-Jen
Lu, Yi-Ching
Wey, Shiaw-Pyng
Wun, Tze-Chein
THROMBOSIS AND HAEMOSTASIS, 2018, 118 (01) : 90 - 102
[7] The rationale for thrombolytic therapy
Califf, RM
EUROPEAN HEART JOURNAL, 1996, 17 : 2 - 8
[8] ADVANCES IN THROMBOLYTIC THERAPY
VERSTRAETE, M
CARDIOVASCULAR DRUGS AND THERAPY, 1992, 6 (02) : 111 - 124
[9] Targeted Thrombolytic Therapy
胡豫
血栓与止血学, 2004, (03) : 99 - 100
[10] Translational initiatives in thrombolytic therapy
Klegerman, Melvin E.
FRONTIERS OF MEDICINE, 2017, 11 (01) : 1 - 19

← 1 2 3 4 5 →